
CognitiveCare is an AI-driven company focused on improving health outcomes across the pharmaceutical, life sciences, and public health sectors. They leverage patented, AI- and physics-based solutions to accelerate drug discovery, optimize clinical trial design, and support post-market success. In public health, they provide data-driven insights for evidence-based policy-making and resource allocation. CognitiveCare differentiates itself by creating ecosystems for robust data ingestion, integrating unstructured and structured data from disparate systems to improve risk stratification and pattern identification. Their impact stories showcase work in maternal and infant well-being, preventing childhood blindness, and managing infectious diseases. The company has received Series A funding and is part of the NVIDIA Inception Program and AWS Healthcare accelerator.

CognitiveCare is an AI-driven company focused on improving health outcomes across the pharmaceutical, life sciences, and public health sectors. They leverage patented, AI- and physics-based solutions to accelerate drug discovery, optimize clinical trial design, and support post-market success. In public health, they provide data-driven insights for evidence-based policy-making and resource allocation. CognitiveCare differentiates itself by creating ecosystems for robust data ingestion, integrating unstructured and structured data from disparate systems to improve risk stratification and pattern identification. Their impact stories showcase work in maternal and infant well-being, preventing childhood blindness, and managing infectious diseases. The company has received Series A funding and is part of the NVIDIA Inception Program and AWS Healthcare accelerator.
Location & founding: Milpitas, CA; founded Feb 2018
Core focus: Healthcare AI for pharma, life sciences, providers, and public health
Flagship product: MIHIC maternal–infant risk scoring / clinical prognostics platform
Team size (reported): ~13 employees
Funding: Seed round Dec 2020; $300,000 reported
Improving health outcomes and decision-making across clinical care, pharmaceutical development, and public health through predictive analytics and integrated data ingestion.
2018
Healthcare AI / Healthtech
$300,000
Reported seed round in Dec 2020; Dealroom lists $300k